<DOC>
	<DOC>NCT02337062</DOC>
	<brief_summary>A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting (PONV).</brief_summary>
	<brief_title>Phase IIIb Study of APD421 in Combination as PONV Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Nausea and Vomiting</mesh_term>
	<mesh_term>Antiemetics</mesh_term>
	<criteria>Male or female patients â‰¥ 18 years of age Patients undergoing elective surgery (open or laparoscopic technique) under general anaesthesia, expected to last at least one hour from induction of anaesthesia to wound closure Patients with at least 3 "Apfel" risk factors for PONV Patients scheduled to undergo transplant surgery Patients scheduled to receive only a local anaesthetic/regional neuraxial (intrathecal or epidural) block Patients who are expected to remain ventilated for a period after surgery Patients who are expected to need a naso or orogastric tube in situ after surgery is completed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>